H E Lebovitz

Summary

Publications

  1. ncbi request reprint Type 2 diabetes: an overview
    H E Lebovitz
    SUNY Downstate Medical Center, 450 Clarkson Ave, Box 1205, Brooklyn, NY 11203, USA
    Clin Chem 45:1339-45. 1999
  2. pmc Fasting plasma triglycerides predict the glycaemic response to treatment of type 2 diabetes by gastric electrical stimulation. A novel lipotoxicity paradigm
    H E Lebovitz
    Department of Medicine, State University of New York Health Science Center at Brooklyn, Brooklyn, NY, USA
    Diabet Med 30:687-93. 2013
  3. ncbi request reprint Oral therapies for diabetic hyperglycemia
    H E Lebovitz
    Department of Medicine, State University of New York Health Science Center at Brooklyn, Brooklyn, New York, USA
    Endocrinol Metab Clin North Am 30:909-33. 2001
  4. ncbi request reprint Rosiglitazone monotherapy is effective in patients with type 2 diabetes
    H E Lebovitz
    Department of Medicine, State University of New York, Brooklyn, New York 11203, USA
    J Clin Endocrinol Metab 86:280-8. 2001
  5. ncbi request reprint Effect of the postprandial state on nontraditional risk factors
    H E Lebovitz
    State University of New York Health Sciences Center, Brooklyn, New York 11203, USA
    Am J Cardiol 88:20H-5H. 2001
  6. doi request reprint New treatments of diabetes: the beta-amylin agonists
    H E Lebovitz
    Health Science Center at Brooklyn, Endocrinology and Metabolism Diabetes, State University of New York, 450 Clarkson Avenue, Brooklyn, NY 11203, USA
    Ann Endocrinol (Paris) 69:147-50. 2008

Collaborators

Detail Information

Publications6

  1. ncbi request reprint Type 2 diabetes: an overview
    H E Lebovitz
    SUNY Downstate Medical Center, 450 Clarkson Ave, Box 1205, Brooklyn, NY 11203, USA
    Clin Chem 45:1339-45. 1999
    ..Long-term glycemic control in type 2 diabetes requires progressive, stepwise, combination treatment with oral agents and eventually combination treatment with oral agents and insulin...
  2. pmc Fasting plasma triglycerides predict the glycaemic response to treatment of type 2 diabetes by gastric electrical stimulation. A novel lipotoxicity paradigm
    H E Lebovitz
    Department of Medicine, State University of New York Health Science Center at Brooklyn, Brooklyn, NY, USA
    Diabet Med 30:687-93. 2013
    ..A preliminary analysis of data from patients who had completed 6 months of treatment indicated that the glycaemic response to the electrical stimulation was inversely related to the baseline fasting plasma triglyceride level...
  3. ncbi request reprint Oral therapies for diabetic hyperglycemia
    H E Lebovitz
    Department of Medicine, State University of New York Health Science Center at Brooklyn, Brooklyn, New York, USA
    Endocrinol Metab Clin North Am 30:909-33. 2001
    ..In choosing combinations of oral antihyperglycemic agents, their effects on the components treatment of type 2 diabetic patients. These classes improve glucose considered, as must the specific effects of the agents on glucose metabolism...
  4. ncbi request reprint Rosiglitazone monotherapy is effective in patients with type 2 diabetes
    H E Lebovitz
    Department of Medicine, State University of New York, Brooklyn, New York 11203, USA
    J Clin Endocrinol Metab 86:280-8. 2001
    ..In the short-term, rosiglitazone is an insulin sensitizer that is effective and safe as monotherapy in patients with type 2 diabetes who are inadequately controlled by lifestyle interventions...
  5. ncbi request reprint Effect of the postprandial state on nontraditional risk factors
    H E Lebovitz
    State University of New York Health Sciences Center, Brooklyn, New York 11203, USA
    Am J Cardiol 88:20H-5H. 2001
    ....
  6. doi request reprint New treatments of diabetes: the beta-amylin agonists
    H E Lebovitz
    Health Science Center at Brooklyn, Endocrinology and Metabolism Diabetes, State University of New York, 450 Clarkson Avenue, Brooklyn, NY 11203, USA
    Ann Endocrinol (Paris) 69:147-50. 2008